Publication: Efficacy and Tolerability of Topiramate
cris.virtual.department | Lietuvos sveikatos mokslų universitetas (302536989) | |
cris.virtual.department | Neurologijos klinika (U524700) | |
cris.virtual.department | Neurologijos klinika (K150000) | |
cris.virtual.department | LSMU ligoninė Kauno klinikos (135163499) | |
cris.virtual.department | MA Kardiologijos institutas (U590000) | |
cris.virtual.department | Lietuvos sveikatos mokslų universitetas (302536989) | |
cris.virtual.department | Neurologijos klinika (U524700) | |
cris.virtual.department | Neurologijos klinika (K150000) | |
cris.virtual.department | LSMU ligoninė Kauno klinikos (135163499) | |
cris.virtual.department | Lietuvos sveikatos mokslų universitetas (302536989) | |
cris.virtual.department | Neurologijos klinika (U524700) | |
cris.virtual.department | Neurologijos klinika (K150000) | |
cris.virtual.department | LSMU ligoninė Kauno klinikos (135163499) | |
cris.virtual.department | Neurologijos klinika (U524700) | |
cris.virtual.department | Lietuvos sveikatos mokslų universitetas (302536989) | |
cris.virtual.department | Neurologijos klinika (K150000) | |
cris.virtual.department | LSMU ligoninė Kauno klinikos (135163499) | |
cris.virtualsource.author-orcid | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.author-orcid | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.author-orcid | e7161b4a-0490-4550-8c63-bedee97447d9 | |
cris.virtualsource.author-orcid | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.author-orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
cris.virtualsource.department | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.department | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.department | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.department | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.department | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.department | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.department | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.department | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.department | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.department | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.department | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.department | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.department | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.department | e7161b4a-0490-4550-8c63-bedee97447d9 | |
cris.virtualsource.department | e7161b4a-0490-4550-8c63-bedee97447d9 | |
cris.virtualsource.department | e7161b4a-0490-4550-8c63-bedee97447d9 | |
cris.virtualsource.department | e7161b4a-0490-4550-8c63-bedee97447d9 | |
cris.virtualsource.orcid | 5590fee2-9dbb-41ff-9dd2-fdcc51e2c43f | |
cris.virtualsource.orcid | e4fa77ee-9444-47b9-a585-d98d9e707882 | |
cris.virtualsource.orcid | ec99b329-100d-48e3-90f5-bb40ccfbae91 | |
cris.virtualsource.orcid | e7161b4a-0490-4550-8c63-bedee97447d9 | |
dc.contributor.author | Endzinienė, Milda | |
dc.contributor.author | Vaičienė, Nerija | |
dc.contributor.author | Jurkevičienė, Giedrė | |
dc.contributor.author | Laurynaitienė, Jūratė | |
dc.contributor.author | Gumbelevičiūtė, Lingvita | |
dc.contributor.author | Lukošiūtė, Laura | |
dc.coverage.spatial | US | |
dc.date.issued | 2005-08-28 | |
dc.description.abstract | Purpose: To investigate the efficacy and tolerability of topiramate (TPM) in refractory childhood epilepsy. Methods: The information about the effects of TPM was collected with the help of a questionnaire filled in by the parents of 66 children with refractory epilepsy. Clinical data were retrieved from medical charts of the patients at Kaunas University Hospital. Results: Mean duration of epilepsy was 64.3 months. Positive effects were observed in 53 (80.3%) cases, with more than 50% seizure reduction in 64%; in 20% it was temporary. [...]. | en |
dc.description.sponsorship | Lietuvos sveikatos mokslų universitetas (302536989) | * |
dc.description.statementofresponsibility | M. Endziniene, N. Vaiciene, G. Jurkeviciene, J. Grigoniene, L. Gumbeleviciute, L. Lukosiute | en |
dc.description.version | Originalus / Original | |
dc.format.extent | p. 238, abstract no. p703. | |
dc.identifier.other | (LSMU ALMA)990000652670107106 | |
dc.identifier.udc | 616.853 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12512/79488 | |
dc.language.iso | en | |
dc.relation.ispartof | Epilepsia : abstracts from the 26th International Epilepsy Congress in Paris 26th IEC proceedings : Paris, France, August 28th– September 1st 2005 / guest editors: Alexis Arzimanoglou, Philippe Ryvlin; Interanational League Against Epilepsy, International Bureau for Epilepsy. Malden, MA : Blackwell Science., 2005, vol. 46, suppl. 6. | |
dc.relation.ispartofseries | Poster session - Paediatric epileptology | |
dc.relation.isreferencedby | Conference Proceedings Citation Index - Science (Web of Science) | |
dc.relation.issn | 0013-9580 | |
dc.subject | Epilepsy | en |
dc.subject | Epilepsy | en |
dc.subject | Anticonvulsants | en |
dc.subject | Fructose | en |
dc.subject.classification | Tezės Web of Science duomenų bazėje / Theses in Web of Science database (T1a1) | |
dc.subject.other | Medicina / Medicine (M001) | |
dc.title | Efficacy and Tolerability of Topiramate | |
dc.type | type::text::conference output::conference proceedings::conference paper | |
dcterms.publisher | Blackwell Publishing | |
dcterms.subject | M | |
dspace.entity.type | Publication | |
local.title | Efficacy and Tolerability of Topiramate / M. Endziniene, N. Vaiciene, G. Jurkeviciene, J. Grigoniene, L. Gumbeleviciute, L. Lukosiute | |
localcerif.author.code | 302536989 | |
localcerif.author.code | 302536989 | |
localcerif.author.code | 302536989 | |
localcerif.author.code | 302536989 | |
localcerif.author.code | 302536989 | |
localcerif.author.code | 302536989 | |
localcerif.pages | 1 | * |
localcerif.title.contributor | M. Endziniene, N. Vaiciene, G. Jurkeviciene, J. Grigoniene, L. Gumbeleviciute, L. Lukosiute | |
localcerif.wos.hash | 36b17a8ee46883155b9a2c042a341cb5 | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) | |
oairecerif.author.affiliation | Lietuvos sveikatos mokslų universitetas (302536989) |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: